Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Short Interest Up 100.8% in December

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOWGet Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 26,100 shares, a growth of 100.8% from the November 30th total of 13,000 shares. Based on an average daily volume of 58,400 shares, the days-to-cover ratio is presently 0.4 days.

Cardio Diagnostics Stock Performance

Shares of NASDAQ CDIOW traded up $0.01 during trading hours on Friday, hitting $0.10. 23,626 shares of the company traded hands, compared to its average volume of 31,163. Cardio Diagnostics has a 12 month low of $0.02 and a 12 month high of $0.28. The company’s 50 day moving average price is $0.05 and its 200 day moving average price is $0.04.

About Cardio Diagnostics

(Get Free Report)

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.

Read More

Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.